Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis

Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis

Background: COVID-19 patients are at high thrombotic risk. The safety and efficacy of different anticoagulation regimens in COVID-19 patients remain unclear. Methods: We searched for randomised controlled trials (RCTs) comparing intermediate- or therapeutic-dose anticoagulation to standard thrombopr...

Full description

Bibliographic Details
Main Authors: Stefanie Reis, Maria Popp, Benedikt Schmid, Miriam Stegemann, Maria-Inti Metzendorf, Peter Kranke, Patrick Meybohm, Stephanie Weibel
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Clinical Medicine
Subjects:
anticoagulant therapy
coronavirus disease 2019
thrombosis
bleeding
death
Online Access:https://www.mdpi.com/2077-0383/11/1/57

Internet

https://www.mdpi.com/2077-0383/11/1/57

Similar Items